3SBio Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | 3SBio Inc.

3SBio Inc. | Ownership

Companies that own 3SBio Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

OppenheimerFunds, Inc.

49,274,000

1.94%

-30,250,000

0.06%

07/31/2018

The Vanguard Group, Inc.

33,260,166

1.31%

223,500

07/31/2018

Harvest Global Investments Ltd.

23,586,500

0.93%

11,822,000

2.33%

07/31/2018

JF Asset Management Ltd.

22,981,500

0.9%

98,500

0.19%

09/03/2018

BlackRock Fund Advisors

22,755,500

0.9%

26,500

07/17/2017

1832 Asset Management LP

19,950,571

0.78%

19,950,571

0.06%

12/31/2017

Norges Bank Investment Management

17,910,539

0.7%

11,831,053

0.01%

12/31/2017

Newton Investment Management Ltd.

17,682,500

0.7%

-2,722,000

0.08%

05/31/2018

HSBC Global Asset Management (Hong Kong) Ltd.

14,612,844

0.56%

2,848,844

0.31%

04/30/2018

T. Rowe Price International Ltd.

14,381,500

0.56%

0.05%

06/30/2018

About 3SBio

View Profile

Address	Shenyang Economy & Tech Development Shenyang Liaoning 110027 China
Employees	-
Website	http://www.3sbio.com
Updated	07/08/2019
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.